Mirati Therapeutics

Mirati Therapeutics

World Rank (Jan-05-2024)
3,416
Market Cap (Jan-05-2024)
4.133 Billion USD
World Rank (Jul-30-2023)
6,294
Market Cap (Jul-30-2023)
1.725 Billion USD
World Rank (Jan-07-2022)
2,422
Market Cap (Jan-07-2022)
7.329 Billion USD
World Rank (Jan-01-2021)
1,568
Market Cap (Jan-01-2021)
11.044 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
MRTX
Employee Count
418
Employee Count as of Date
As on 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
12 Million USD
Annual Operating Income in USD
-759 Million USD
Annual Net Income in USD
-740 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
1,202 Million USD
Total Liabilities in USD
206 Million USD
Total Equity in USD
996 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
HealthCare Products
Biotechnology
Company Website
MIRATI THERAPEUTICS INC
Yahoo
Yahoo @ Nasdaq
Company Profile

Mirati Therapeutics is a Bio Technology and Clinical Collaboration company. The headquarters is in USA.

Annual Results Summary

MIRATI THERAPEUTICS - Annual Results Summary - in Million USD

Year Ending:Total RevenueOperating IncomeNet Income
Dec-202212-759 (Loss)-740 (Loss)
Dec-202172-573 (Loss)-582 (Loss)
Dec-202013(369) (Loss)(358) (Loss)
Dec-20193(222) (Loss)(213) (Loss)
Dec-201813(103) (Loss)(98) (Loss)
Dec-20170(72) (Loss)(70) (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,202 Million USD.

Total Liabilities as on Dec-2022 was 206 Million USD.

Total Equity as on Dec-2022 was 996 Million USD.

Founded Year
1995
Stock Exchange
Nasdaq
Frankfurt
Company SubCategory
Top Healthcare Companies in USA
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share